Masuho Saburi

Oita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndrome with anti-HLA antibodies

Unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndrome with anti-HLA antibodies

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 03, 2026

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy.

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 28, 2026

CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Journal: Leukemia research reports

Published: May 18, 2026

Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity.

Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity.

Journal: Cureus

Published: May 06, 2026

Successful Treatment of Adult Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis With Etoposide Guided by Plasma Epstein-Barr Virus DNA Monitoring: A Case Report.

Successful Treatment of Adult Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis With Etoposide Guided by Plasma Epstein-Barr Virus DNA Monitoring: A Case Report.

Journal: EJHaem

Published: March 17, 2026

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Journal: British journal of haematology

Published: March 12, 2026

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma.

Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma.

Journal: Hematological oncology

Published: October 13, 2025

Bing-Neel Syndrome in Waldenström Macroglobulinemia: Updates on Clinical Management and BTK Inhibitor Efficacy.

Bing-Neel Syndrome in Waldenström Macroglobulinemia: Updates on Clinical Management and BTK Inhibitor Efficacy.

Journal: Cancers

Published: September 22, 2025

Disease Control and Manageable Toxicity With Epcoritamab in Refractory Diffuse Large B-Cell Lymphoma-Type Richter Syndrome: A Case Report in an Elderly Patient.

Disease Control and Manageable Toxicity With Epcoritamab in Refractory Diffuse Large B-Cell Lymphoma-Type Richter Syndrome: A Case Report in an Elderly Patient.

Journal: Cancer reports (Hoboken, N.J.)

Published: May 14, 2025

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

Journal: American journal of hematology

Published: March 10, 2025

Outcome of allogeneic hematopoietic stem cell transplantation for myelofibrosis

Outcome of allogeneic hematopoietic stem cell transplantation for myelofibrosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 05, 2025

Showing 1-12 of 63

Last Updated: 09/26/2026